Time to Initiation of the Second-Line Therapy Obeticholic Acid in Patients With Primary Biliary Cholangitis

被引：0
|
作者：
Kumar, Sonal [1 ]
Macewan, Joanna P. [2 ]
Levine, Alina [2 ]
Bessonova, Leona [3 ]
Nair, Radhika [3 ]
Wheeler, Darren [3 ]
Li, Jing [3 ]
Brown, Robert S. [1 ]
机构：
[1] Weill Cornell Med Coll, New York, NY USA
[2] Genesis Res Grp, Hoboken, NJ USA
[3] Intercept Pharmaceut Inc, Morristown, NJ USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001028872.30928.6d
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S126
引用
收藏
页码：S91 / S91
页数：1
相关论文
共 50 条
  • [41] Reductions in Abnormal Direct Bilirubin with Obeticholic Acid in Patients with Primary Biliary Cholangitis
    Pares, Albert
    Vargas, Victor
    Shiffman, Mitchell L.
    Hirschfield, Gideon M.
    Invernizzi, Pietro
    Liberman, Alexander
    Malecha, Elizabeth Smoot
    Owens-Grillo, Janet
    Lopez-Talavera, Juan C.
    HEPATOLOGY, 2017, 66 : 174A - 174A
  • [42] EFFECTS OF OBETICHOLIC ACID ON APRI AND GLOBE SCORE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS
    Harms, Maren H.
    Hirschfield, Gideon
    Floreani, Annarosa
    Mayo, Marlyn J.
    Pares, Albert
    Liberman, Alexander
    Malecha, Elizabeth Smoot
    Pencek, Richard
    MacConell, Leigh
    Hansen, Bettina E.
    HEPATOLOGY, 2019, 70 : 763A - 764A
  • [43] Bezafibrate improves the effect of obeticholic acid on cholestasis in patients with primary biliary cholangitis
    Smets, Lena
    Liliane, Schrijvers
    Hannelie, Korf
    Schalk, Van der Merwe
    Frederik, Nevens
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E130 - E130
  • [44] Real-World Effectiveness of Obeticholic Acid in Patients with Primary Biliary Cholangitis
    Roberts, Surain B.
    Ismail, Marwa
    Kanagalingam, Gowthami
    Mason, Andrew L.
    Swain, Mark G.
    Vincent, Catherine
    Yoshida, Eric M.
    Tsien, Cynthia
    Flemming, Jennifer A.
    Janssen, Harry L. A.
    Hirschfield, Gideon M.
    Hansen, Bettina E.
    Gulamhusein, Aliya F.
    HEPATOLOGY COMMUNICATIONS, 2020, 4 (09) : 1332 - 1345
  • [45] Improving Primary Biliary Cholangitis Outcomes in the Evolving Landscape of Second-Line Therapies
    Scaravaglio, Miki
    Ronca, Vincenzo
    Carbone, Marco
    Invernizzi, Pietro
    LIVER INTERNATIONAL, 2025, 45 (03)
  • [46] REAL WORLD APPLICABILITY OF OBETICHOLIC ACID FOR PRIMARY BILIARY CHOLANGITIS
    Kesavarapu, Keerthana
    Rothstein, Kenneth
    Riera, Andres R.
    Patel, Vishal
    Munoz, Santiago J.
    GASTROENTEROLOGY, 2017, 152 (05) : S1187 - S1187
  • [47] Effectiveness of obeticholic acid (OCA) in southern European patients with primary biliary cholangitis (PBC) as a second line therapy. A multicenter, international, real-world cohort
    Garcia-Buey, Luisa
    Casado, Marta
    Jorquera, Francisco
    Olveira Martin, Antonio
    Molina, Esther
    Conde, Isabel
    Berenguer Haym, Marina
    Gomez Dominguez, Elena
    Hernandez Guerra, Manuel
    Maia, Luis
    Pedroto, Isabel
    Santos, Arsenio
    Carvalho, Armando
    Mesquita, Monica
    Presa, Jose
    Morillas, Rosa
    Angel Simon, Miguel
    Ignacio Arenas, Juan
    Manuel Sousa-Martin, Jose
    Costa-Moreira, Pedro
    Macedo, Guilherme
    Antonio Carrion, Jose
    Uriz Otano, Juan Isidro
    Luisa Gutierrez, Maria
    Fernandez Rodriguez, Conrado Manuel
    JOURNAL OF HEPATOLOGY, 2020, 73 : S464 - S464
  • [48] Resolution of Jaundice in a Patient With Primary Biliary Cholangitis on Obeticholic Acid
    Barnhill, Michele
    Rangnekar, Amol
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S1192 - S1192
  • [49] Obeticholic acid in primary biliary cholangitis: where we stand
    Manne, Vignan
    Kowdley, Kris V.
    CURRENT OPINION IN GASTROENTEROLOGY, 2019, 35 (03) : 191 - 196
  • [50] Management of primary biliary cholangitis prior to obeticholic acid availability
    Durazzo, Marilena
    Bonetto, Silvia
    Fagoonee, Sharmila
    Morgando, Anna
    Pellicano, Rinaldo
    MINERVA MEDICA, 2018, 109 (06) : 410 - 417
12345